SG11202108225QA - Methods and compositions for treating sleep apnea - Google Patents
Methods and compositions for treating sleep apneaInfo
- Publication number
- SG11202108225QA SG11202108225QA SG11202108225QA SG11202108225QA SG11202108225QA SG 11202108225Q A SG11202108225Q A SG 11202108225QA SG 11202108225Q A SG11202108225Q A SG 11202108225QA SG 11202108225Q A SG11202108225Q A SG 11202108225QA SG 11202108225Q A SG11202108225Q A SG 11202108225QA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- methods
- sleep apnea
- treating sleep
- treating
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 201000002859 sleep apnea Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962803223P | 2019-02-08 | 2019-02-08 | |
| PCT/US2020/017323 WO2020163785A1 (en) | 2019-02-08 | 2020-02-07 | Methods and compositions for treating sleep apnea |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108225QA true SG11202108225QA (en) | 2021-08-30 |
Family
ID=71947080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108225QA SG11202108225QA (en) | 2019-02-08 | 2020-02-07 | Methods and compositions for treating sleep apnea |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220096401A1 (ja) |
| EP (1) | EP3920898A4 (ja) |
| JP (1) | JP2022519721A (ja) |
| KR (1) | KR20210125507A (ja) |
| CN (1) | CN113692277A (ja) |
| AU (1) | AU2020219809A1 (ja) |
| BR (1) | BR112021015600A2 (ja) |
| CA (1) | CA3129270A1 (ja) |
| EA (1) | EA202192202A1 (ja) |
| IL (1) | IL285197A (ja) |
| MX (1) | MX2021009407A (ja) |
| SG (1) | SG11202108225QA (ja) |
| WO (1) | WO2020163785A1 (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020015316A2 (pt) | 2018-01-30 | 2020-12-08 | Apnimed, Inc. (Delaware) | Métodos e composições para o tratamento da apneia do sono |
| JP2024511091A (ja) * | 2021-03-24 | 2024-03-12 | アプニメッド，インコーポレイテッド（デラウェア） | 睡眠時無呼吸を治療するための方法及び組成物 |
| WO2022266440A1 (en) * | 2021-06-17 | 2022-12-22 | Apnimed, Inc. (Delaware) | Norepinephrine reuptake inhibitors for treating sleep apnea |
| WO2023219991A1 (en) * | 2022-05-13 | 2023-11-16 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
| WO2024049885A1 (en) * | 2022-09-02 | 2024-03-07 | Apnimed, Inc. (Delaware) | Methods and compositions for treating sleep apnea |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| WO2006023702A2 (en) * | 2004-08-20 | 2006-03-02 | Cypress Bioscience, Inc. | Method for treating sleep related breathing disorders with setiptiline |
| WO2006055854A2 (en) * | 2004-11-17 | 2006-05-26 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtazapine treatment |
| US8512751B2 (en) * | 2004-12-20 | 2013-08-20 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
| FR2889811B1 (fr) * | 2005-08-19 | 2009-10-09 | Sanofi Aventis Sa | Association d'un agent hypnotique a duree d'action longue et d'un agent hypnotique a duree d'action courte, composition pharmaceutique la contenant et son application en therapeutique. |
| NZ580250A (en) * | 2007-04-09 | 2012-05-25 | Sunovion Pharmaceuticals Inc | Methods and compositions comprising desmethylvenlafaxine or duloxetine for treating sleep-related breathing disorders |
| WO2009086046A1 (en) * | 2007-12-21 | 2009-07-09 | Eurand, Inc. | Orally disintegrating tablet compositions of temazepam |
| CA3002544C (en) * | 2015-04-27 | 2024-03-05 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| US10004749B2 (en) * | 2015-07-22 | 2018-06-26 | John Hsu | Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof |
| CN110799181A (zh) * | 2017-04-28 | 2020-02-14 | 布里格姆妇女医院 | 用于治疗睡眠呼吸暂停的方法和组合物 |
-
2020
- 2020-02-07 BR BR112021015600-3A patent/BR112021015600A2/pt unknown
- 2020-02-07 EA EA202192202A patent/EA202192202A1/ru unknown
- 2020-02-07 US US17/428,596 patent/US20220096401A1/en active Pending
- 2020-02-07 CN CN202080026282.6A patent/CN113692277A/zh active Pending
- 2020-02-07 AU AU2020219809A patent/AU2020219809A1/en active Pending
- 2020-02-07 CA CA3129270A patent/CA3129270A1/en active Pending
- 2020-02-07 EP EP20752195.6A patent/EP3920898A4/en active Pending
- 2020-02-07 KR KR1020217027063A patent/KR20210125507A/ko unknown
- 2020-02-07 SG SG11202108225QA patent/SG11202108225QA/en unknown
- 2020-02-07 MX MX2021009407A patent/MX2021009407A/es unknown
- 2020-02-07 JP JP2021546285A patent/JP2022519721A/ja active Pending
- 2020-02-07 WO PCT/US2020/017323 patent/WO2020163785A1/en unknown
-
2021
- 2021-07-28 IL IL285197A patent/IL285197A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3129270A1 (en) | 2020-08-13 |
| EP3920898A4 (en) | 2022-11-09 |
| WO2020163785A1 (en) | 2020-08-13 |
| EP3920898A1 (en) | 2021-12-15 |
| AU2020219809A1 (en) | 2021-08-19 |
| US20220096401A1 (en) | 2022-03-31 |
| CN113692277A (zh) | 2021-11-23 |
| JP2022519721A (ja) | 2022-03-24 |
| IL285197A (en) | 2021-09-30 |
| KR20210125507A (ko) | 2021-10-18 |
| EA202192202A1 (ru) | 2021-11-03 |
| MX2021009407A (es) | 2021-09-10 |
| BR112021015600A2 (pt) | 2021-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201907158B (en) | Methods and compositions for treating sleep apnea | |
| IL276247A (en) | Methods and materials for the treatment of sleep apnea | |
| IL282600A (en) | Composition and method for health care | |
| IL285197A (en) | Methods and preparations for the treatment of sleep apnea | |
| IL271503A (en) | Preparations and treatments for sleep disorders | |
| ZA202207394B (en) | Compositions and methods for treating hemoglobinopathies | |
| PL3253443T3 (pl) | Urządzenie do leczenia chrapania i bezdechu sennego | |
| EP3866736A4 (en) | METHODS AND DEVICES FOR THE TREATMENT OF SLEEP APNEA | |
| IL285886A (en) | Preparations and methods for the treatment of laminopathy | |
| IL280413A (en) | Bismuth-thiol preparations and wound treatment methods | |
| SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
| IL290348B1 (en) | Compositions and methods for surface treatment | |
| SG11202102442WA (en) | Methods and compositions for preventing and treating atherosclerosis and related diseases | |
| IL288440A (en) | Materials and methods for the treatment of retinopathy | |
| IL260929B (en) | Dental appliance system and method of forming thereof for treating sleep apnea | |
| EP3589344A4 (en) | SOUND ATTENUATION STRUCTURES AND METHODS FOR USE IN THE TREATMENT OF OBSTRUCTIVE SLEEP APNEA | |
| IL307186A (en) | Methods and preparations for treating sleep apnea | |
| IL304771A (en) | Preparations and methods for the treatment of a disease associated with dux4 overexpression | |
| PT3810128T (pt) | Composições para tratar e/ou prevenir doenças de agregação de proteinas | |
| IL292186A (en) | Preparations and methods for treating blood disorders | |
| IL285796A (en) | Methods and preparations for the treatment of cancer | |
| EP3746068A4 (en) | COMPOSITIONS AND METHODS OF TREATMENT OF OBSTRUCTIVE SLEEP APNEA | |
| EP4069253A4 (en) | METHOD AND COMPOSITIONS FOR TREATING GLIOBLASTOMA | |
| SG11202107355RA (en) | Improved method and compositions for surface treatment | |
| GB201913589D0 (en) | Systems and methods for reducing snoring and/or sleep apnea |